Drug Delivery Devices - United Arab Emirates

United Arab Emirates

Highlights

In the United Arab Emirates, revenue in the Drug Delivery Devices market market is projected to reach US$104.30m in 2024.
The revenue is expected to demonstrate an annual growth rate (CAGR 2024-2029) of 7.90%, leading to a market volume of US$152.50m by 2029.
In a global context, the highest revenue is anticipated to be generated the United States, which is forecasted to reach US$15.01bn in 2024.
The United Arab Emirates is witnessing a surge in innovative drug delivery devices, driven by advancing healthcare infrastructure and increasing demand for patient-centric solutions.

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Drug Delivery Devices Market within the Medical Devices sector in the United Arab Emirates is experiencing moderate growth. This growth is influenced by factors such as advancements in technology, increasing healthcare expenditures, and a growing emphasis on patient-centric solutions.

Customer preferences: Consumers in the United Arab Emirates are increasingly favoring personalized and convenient drug delivery solutions, reflecting a shift towards patient-centric healthcare. This trend is fueled by a growing awareness of chronic diseases and the desire for efficient management options. Additionally, the rise of telemedicine and home healthcare services has led to a demand for innovative delivery devices that can facilitate self-administration. Cultural emphasis on wellness and proactive health management further drives the adoption of advanced drug delivery technologies, aligning with modern lifestyle shifts.

Trends in the market: In the United Arab Emirates, the Drug Delivery Devices Market is experiencing a significant shift towards smart and user-friendly solutions, driven by the demand for personalized healthcare. The integration of digital health technologies is enhancing patient engagement, enabling real-time monitoring and adherence to treatment regimens. Furthermore, the rising prevalence of chronic conditions is fostering innovation in devices that support self-administration, such as autoinjectors and wearable delivery systems. This evolution in drug delivery not only caters to patient preferences but also presents opportunities for industry stakeholders to develop advanced solutions that align with the region's healthcare goals.

Local special circumstances: In the United Arab Emirates, the Drug Delivery Devices Market is uniquely influenced by its diverse expatriate population and high standard of living, which drive demand for advanced healthcare solutions. The integration of Islamic principles into healthcare practices shapes patient preferences, emphasizing the need for culturally sensitive designs. Additionally, robust regulatory frameworks promote innovation while ensuring safety, fostering collaboration between local and international companies. These factors collectively enhance the market's dynamism, encouraging the development of cutting-edge delivery systems tailored to the region's specific health challenges and demographic needs.

Underlying macroeconomic factors: The Drug Delivery Devices Market in the United Arab Emirates is significantly influenced by macroeconomic factors such as national economic stability, investment in healthcare infrastructure, and global economic trends. The UAE's strong economic performance, bolstered by diversification efforts and high GDP per capita, supports increased healthcare spending and innovation in medical technologies. Additionally, favorable fiscal policies, including government initiatives to enhance healthcare access and quality, further stimulate market growth. The rising prevalence of lifestyle-related diseases within the expatriate population also drives demand for advanced drug delivery solutions, aligning with global health trends and technological advancements.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Explore more high-quality data on related topic

Medical technology industry - statistics & facts

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.